Joint Symptoms and Disorder

You have full text access to this OnlineOpen article

Association between the use of serotonin receptor 2A–blocking antidepressants and joint disorders

  1. Anders Kling1,*,
  2. Marit Danell-Boman1,
  3. Hans Stenlund2,
  4. Rune Dahlqvist1

Article first published online: 29 SEP 2009

DOI: 10.1002/art.24673

Issue

Arthritis Care & Research

Arthritis Care & Research

Volume 61, Issue 10, pages 1322–1327, 15 October 2009

Additional Information

How to Cite

Kling, A., Danell-Boman, M., Stenlund, H. and Dahlqvist, R. (2009), Association between the use of serotonin receptor 2A–blocking antidepressants and joint disorders. Arthritis & Rheumatism, 61: 1322–1327. doi: 10.1002/art.24673

Author Information

  1. 1

    University Hospital, Umeå, Sweden

  2. 2

    Umeå University, Umeå, Sweden

*Division of Clinical Pharmacology, University Hospital, SE-901 85 Umeå, Sweden

Publication History

  1. Issue published online: 29 SEP 2009
  2. Article first published online: 29 SEP 2009
  3. Manuscript Accepted: 18 MAY 2009
  4. Manuscript Received: 17 DEC 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (75K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rajeev Krishnadas, Ranjit Krishnadas, Jonathan Cavanagh, Sustained remission of rheumatoid arthritis with a specific serotonin reuptake inhibitor antidepressant: a case report and review of the literature, Journal of Medical Case Reports, 2011, 5, 1, 112

    CrossRef

View Full Article (HTML) Get PDF (75K)